Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

Delayed Data
As of Jun 15
 +1.36 / +1.13%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Alexion Pharmaceuticals Inc have a median target of 163.50, with a high estimate of 184.00 and a low estimate of 115.00. The median estimate represents a +34.55% increase from the last price of 121.52.

Analyst Recommendations

The current consensus among 21 polled investment analysts is to Buy stock in Alexion Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jul 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.55%
Growthannually 19.40%


Growthquarterly 5.05%
Growthannually 12.44%
Key to the earnings and sales forecast charts.